ATHE (ATHE) Stock Price & Analysis
ATHE (ATHE) rose 0.44% to USD 4.54 as of September 8, 2026 at 05:48 UTC, according to Nexqual real-time market data.
ATHE last closed at USD 4.54; the session ranged USD 4.45–4.55 on volume of 4,563 shares. Market capitalization is —, with a 52-week range of USD 2.66–5.89 (NCM). Source: Nexqual, September 8, 2026 at 05:48 UTC.
Key Statistics (as of September 8, 2026 at 05:48 UTC)
| Price | USD 4.54 |
|---|---|
| Change | ▲ 0.44% (up) |
| Previous Close | USD 4.54 |
| Open | USD 4.54 |
| Day Range | USD 4.45 – 4.55 |
| 52-Week Range | USD 2.66 – 5.89 |
| Volume | 4,563 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (ATHE)
Nexqual's technical model rates ATHE "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 05:48 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 45.4 (neutral) |
| vs SMA50 | Below (USD 4.8) |
| MACD | -0.05 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IMRN | Immuron Limited | USD 1.8 | ▲ 53.85% |
| EDSA | Edesa Biotech, Inc. | USD 4.73 | ▼ 0.63% |
| RKTO | Rocket One Inc. | USD 0.69 | ▲ 0.48% |
| PHIO | Phio Pharmaceuticals Corp. | USD 1.08 | ▼ 4.42% |
| ADIL | Adial Pharmaceuticals, Inc | USD 7.12 | ▲ 12.66% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:48 UTC. This page is informational and not investment advice.